India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Axis Ban 477.15 7.02
Icici Ba 263.55 3.78
State Ba 245.80 2.13
Reliance 892.75 2.12
Ong Corp 173.55 1.37
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:524715NSE:SUNPHARMABloomberg:SUNP@INReuters:SUN.BO
Market Lot: 1Face Value: 1ISIN Demat: INE044A01036
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
13-Oct-2017       Sun Pharma to hike stake in Ranbaxy Malaysia to 79.5% IRIS
12-Oct-2017       Sun Pharma receives EIR from USFDA for Dadra facility IRIS
20-Sep-2017       Sun Pharma's arm receives USFDA approval for new label for Odomzo IRIS
09-Aug-2017       Sun Pharma to acquire 15.91% stake in Krystal Biotech IRIS
10-Jul-2017       Sun Pharma settles Modafinil antitrust litigation matter in US IRIS
04-Jul-2017       Sun Pharma enters into manufacturing pact with Samsung BioLogics IRIS
27-Jun-2017       Sun Pharma, NIV ink pact to fight Zika, Chikungunya and Dengue IRIS
13-Jun-2017       Sun Pharma gains on receiving USFDA approval for generic version of Zetia tablets IRIS
13-Jun-2017       Sun Pharma announces USFDA approval for generic Zetia tablets IRIS
24-May-2017       Sun Pharma gets USFDA approval for Tildrakizumab BLA IRIS
17-Mar-2017       Sun Pharma's arm to acquire Thallion Pharmaceuticals IRIS
15-Mar-2017       Angel Broking maintains 'Buy' on Sun Pharmaceutical IRIS
14-Mar-2017       USFDA lifts import alert from Sun Pharma's Mohali unit IRIS
05-Jan-2017       Sun Pharma successfully conducts phase 3 confirmatory clinical trial results for Seciera IRIS
23-Dec-2016       Sun Pharma's arm acquires 14.58% stake in scPharmaceuticals IRIS
22-Dec-2016       Sun Pharma climbs on inking agreement to acquire branded oncology product 'Odomzo' IRIS
22-Dec-2016       Sun Pharma to acquire Odomzo from Novartis IRIS
21-Dec-2016       Sun Pharma acquires 85% stake in JSC Biosintez IRIS
20-Dec-2016       Sun Pharma announces voluntary withdrawal of 28 ANDAs IRIS
12-Dec-2016       Sun Pharma inks licensing pact with Moebius Medical IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer